Our Firm is representing numerous Rejuvenate and ABG II hip stem recipients who may be eligible to participate in this settlement program. We will continue to monitor developments pertaining to this matter closely.
New York, New York (PRWEB) November 18, 2014
Matters relating to the recently-announced Stryker hip lawsuit (http://www.consumerinjurylawyers.com/stryker-rejuvenate/stryker-hip-lawsuits/) settlement agreement continue to move forward in courts around the country, Bernstein Liebhard LLP reports. According to an Order issued on November 13, 2014 in New Jersey’s Bergen County Superior Court, all potential Stryker hip recall claims must be registered by December 14, 2014. The Order, which was issued in cooperation with the Stryker hip recall litigation underway in U.S. District Court, District of Minnesota, as well other state courts, applies to both filed and un-filed Stryker hip lawsuits, as well as claims for Rejuvenate and ABG II hip stem recipients who have not yet required revision surgery. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
Among other things, the November 13th Order notes that that registration in no way commits any claimant to enroll in the Stryker hip lawsuit settlement program. Following registration, those claimants who do wish to accept the terms of the settlement must enroll in the program between January 15, 2015 and March 2, 2015.
“Our Firm is representing numerous Rejuvenate and ABG II hip stem recipients who may be eligible to participate in this settlement program. We will continue to monitor developments pertaining to this matter closely,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals affected by the Stryker hip recall.
Stryker Hip Litigation
Stryker announced a worldwide recall for Rejuvenate and ABG II hip stems in July 2012, after the metal components were found to be vulnerable to fretting and corrosion at the modular-neck junction. Since then, court documents indicate that more than 5,000 Stryker hip lawsuits have been filed in U.S. courts on behalf of individuals who suffered complications allegedly associated with the devices. This includes more than 2,148 claims pending in New Jersey, as well as at least 2,148 Stryker hip lawsuits that have been filed in the District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)
The Stryker hip settlement program was announced in Bergen County Superior Court on November 3, 2014, and could resolve the thousands of Rejuvenate and ABG II lawsuits now pending in state and federal courts throughout the U.S. According to court documents, the global settlement program provides for gross base awards of $300,000 per failed implant, with potential deductions and enhancements based on the particulars of each case, including additional compensation for claimants who suffered complications during revision surgery and for other damages, including future surgeries caused by complications. The settlement also provides compensation for individuals who need a revision but are medically unable to undergo the surgery. Claimants may begin receiving their awards by the summer of 2015.
There is no overall cap or fixed fund for Stryker’s liability under this settlement program. According to the Associated Press, Stryker has disclosed that it will pay at least $1.43 billion to fulfill the terms of the agreement.**
Rejuvenate and ABG II hip stem recipients may be eligible for compensation if they experienced complications related to the Stryker hip recall. To learn more, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
**http://www.chicagobusiness.com/article/20141103/NEWS04/141109967/stryker-to-pay-1-43-billion-to-settle-hip-implant-cases, Associated Press, November 3, 2014
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP